Tamsulosin in the treatment of patients with ureteroliths of the lower third of the ureter clinical and pharmacoeconomic grounds
- Авторлар: Avdoshin VP1, Andryukhin MI1, Barabash MI1, Taskinen Y.l1, Olshanskaya EV1, Motin PI1, Khaidar M1
-
Мекемелер:
- Шығарылым: № 4 (2005)
- Беттер: 36-39
- Бөлім: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/276628
- ID: 276628
Дәйексөз келтіру
Толық мәтін
Аннотация
Alphal-adrenoblocker tamsulosin reduces muscle spasm in the ureteric wall, decreases peristalsis below and raises pressure above the stone thus facilitating stone passage. Patients on tamsulosin had spontaneous stone passage in 73.8% cases while only 22.4% patients on routine therapy became stone free. Tamsulosin also shortens hospital stay. Use of tamsulosin 0.4 mg daily in patients with distal ureteric stones is pathogenetically validated, is highly clinically and cost effective.
Әдебиет тізімі
- Тиктинский О. Л., Александров В. П. Мочекаменная болезнь. СПб.; 2000.
- Miller О. F., Капе С. J. Time to stone passage for observed ureteral calculi: a guide for patient education. J. Urol. (Baltimore) 1999; 162: 688.
- Ueno A., Kawamura T., Ogawa A., Takayasy H. Relation of spontaneous passage of ureteral calculi to size. Urology 1977; 10: 544.
- Kinder R. В., Osborn D. E., Flynn J. Т., Smart J. G. Ureteroscopy and ureteric calculi; how useful? Br. J. Urol. 1987; 60: 506.
- Whithfield H. N. The management of ureteric stones. Part II: therapy. Br. J. Urol. Int. 1999; 84: 916.
- Sander W. В., Bajor G. Beta-blocking agent facilitating the spontaneous passage of ureteral stones. Int. Urol. Nephrol. 1990; 22: 33.
- Porpiglia F., Destefanis P., Fiori C., Fontana D. Effectiveness of nifedipine and defiasacort in the management of distal ureteral stones. Urology 2000; 56: 579.
- Cooper J. Т., Stack G. M., Cooper T. P. Intencieve medical management of ureteral calculi. Urology 2000; 56: 575.
- Borghl L., Meschi Т., Amato F. et al. Nifedipine and methylprednisolone in facilitating ureteral stone passage: a randomized, double-blind, placebo-controlled study. J. Urol. (Baltimore) 1994; 152: 1095.
- Wilde M. L., McTravish D. Tamsulosin. A review of its pharmacological properties and therapeutic potential in the management of symptomatic benigh prostatic hyperplasia. Drags 1996; 52 (6): 883-898.
- Sigala S., Dellabella M., Milanese G. et al. Alphal adrenoreceptor subtypes in menjuxtavesical ureters: molecular and pharmacological characterization. Eur. Urol. Suppl. 2004; 3: abstr. 465.
- Richardson С. D., Donatucci С. F., Page S. O. et al. Pharmacology of tamsulosin saturation-binding isotherms and competition analysis using cloned alpha I-adrenergic receptor subtypes. Prostate 1997; 33: 55.
Қосымша файлдар
